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Abstract
Background: This systematic review summarized recent evidence pertaining to the clinical effectiveness of 64-slice
or higher computed tomography angiography (CTA) in patients with suspected coronary artery disease (CAD). If
CTA proves to be a successful diagnostic performance measure, it could prevent the use of invasive diagnostic
procedures in some patients. This would provide multiple health and cost benefits, particularly for under resourced
areas where invasive coronary angiography is not always available.
Methods: A systematic method of literature searching and selection was employed with searches limited to December
2006 to March 2009. Included studies were quality assessed using National Health and Medical Research Council
(NHMRC) diagnostic levels of evidence and a modified Quality Assessment of Diagnostic Accuracy Studies (QUADAS)
tool. Individual and pooled diagnostic performance measures were calculated using standard meta-analytic techniques
at the patient, vessel and segment level. A positive result was defined as greater than or equal to 50% stenosis.
Results: Twenty-eight studies were included in the systematic review examining 3,674 patients. The primary meta-
analysis at the patient-level indicated a sensitivity of 98.2% and specificity of 81.6%. The median (range) positive
predictive value (PPV) was 90.5% (76%-100%) and negative predictive value (NPV) 99.0% (83%-100%). In all vessels,
the pooled sensitivity was 94.9%, specificity 89.5%, and median (range) PPV 75.0% (53%-95%) and NPV 99.0% (93%-
100%). At the individual artery level, overall diagnostic accuracy appeared to be slightly higher in the left main
coronary artery and slightly lower in the left anterior descending and circumflex artery. In all segments, the
sensitivity was 91.3%, specificity 94.0% and median (range) PPV 69.0% (44%-86%) and NPV 99.0% (98%-100%).
Conclusions: The high sensitivity indicates that CTA can effectively identify the majority of patients with significant
coronary artery stenosis. The high NPV at the patient, vessel and segment level establishes CTA as an effective non-
invasive alternative to invasive coronary angiography (ICA) for the exclusion of stenosis.
Background
Coronary artery disease (CAD) is the leading cause of
death and disability in the U.S. and other Western coun-
tries [1]. Detecting and assessing the extent of CAD has
become increasingly important so that early intervention
can be applied to decrease morbidity and mortality.
When patients present with suspected CAD, a resting
electrocardiogram (ECG) is normally performed in the
first instance. If this is normal or equivocal, an exercise
stress test will usually follow. If this remains inconclu-
sive, invasive coronary angiography (ICA) is often per-
formed. ICA allows ad hoc performance of coronary
interventions such as percutaneous coronary interven-
tion (PCI), however only one third of all ICAs are per-
formed in conjunction with a revascularisation
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nostic purposes [2].
Due partly to its high cost, but also because of the
associated mortality and morbidity, it has been sug-
gested that ICA is not ideal as a widespread diagnostic
procedure thus prompting interest in the development
of non-invasive coronary imaging [3]. The most serious
complications of ICA are death (0.1-0.2%), non-fatal
myocardial infarction (MI) (0.1%) and cerebrovascular
accidents (0.1%) [4-6]. Other complications include
arrhythmias, vasovagal reactions, infections and allergic
dye reactions. Exercise ECG is widely used for non-inva-
sive detection of CAD owing to its ready availability and
relatively low cost [7]. Other non-invasive techniques
such as computed tomography angiography (CTA) have
been developed to assist in the risk assessment process.
At present, CTA is mainly used for detecting or exclud-
ing significant coronary stenosis (≥50% diameter reduc-
tion) in coronary arteries. Recently, there has been
considerable enhancement in temporal and spatial reso-
lution, which has been reported to result in clinical ben-
efit in terms of improved diagnostic accuracy [8]. The
newer multi-detector machines can produce more
images in less time, thereby increasing throughput and
theoretically decreasing the cost per patient.
Despite this, owing mainly to its high temporal and
spatial resolution, ICA remains the diagnostic criterion
standard for clinical evaluation of known or suspected
CAD. It is conducted both to assist with determining
the extent of CAD and to help guide cardiac interven-
tions to treat these disorders. Although CTA is less
invasive, carries a lower risk of serious complications,
and is cheaper than ICA, concerns about its accuracy in
excluding patients without significant stenosis has pre-
vented it becoming a diagnostic test of choice for clini-
cians [9].
This systematic review aimed to summarise recent evi-
dence pertaining to the clinical effectiveness of 64-slice
CTA in patients with suspected CAD. While true that it
is based on a previous systematic review, this study pro-
vides the most recent diagnostic performance informa-
tion from studies of 64-slice CT angiography in patients
with suspected CAD. It is important to note there has
been a significant volume of new literature published on
this topic in recent years. If CTA proves to be a success-
ful diagnostic performance measure, it could prevent the
application of invasive diagnostic procedures in some
patients. It may be of particular value in settings where
patients do not have ready access to ICA.
Methods
Literature search
This systematic review, commissioned by the New Zeal-
and Ministry of Health, was based on a previous health
technology assessment (HTA) of the clinical effective-
ness and cost-effectiveness of 64-slice or higher CTA as
an alternative to ICA in the investigation of CAD [10].
The HTA report had a search date end of December
2006. For this review, searches were limited to English
language material published from between December
2006 and March 2009. The primary computerized
search was conducted by cross-searching EMBASE,
Medline, the Cochrane library and HTA databases. Indi-
vidual search strategies for each electronic database,
using relevant subject headings, were undertaken based
on the literature search by Mowatt et al [10]. These
included the following keywords: coronary artery dis-
ease, myocardial ischemia, ischemic heart disease, myo-
cardial infarction, chest pain, angina, stenosis, computed
tomography, computer assisted tomography, computed
tomographic angiography, invasive coronary angiography
and coronary angiogram.
Study eligibility
Titles and abstracts of identified studies were screened
for possible inclusion or exclusion before retrieving full
text versions of the publications. Included studies were
those that compared the diagnostic accuracy of CTA to
ICA in patients with suspected CAD. As opposed to the
broader review by Mowatt et al [10], this review did not
i n c l u d ep r o g n o s t i cs t u d i e s ,t echnical studies (e.g. image
quality), assessment studies, or post-revascularisation
studies. Citations were excluded if they were reported as
a conference abstract, not a diagnostic performance
study; they included the wrong intervention (i.e. not 64-
slice or higher CTA); they did not report diagnostic per-
formance results relating to the identified outcome of
interest (≥50% stenosis); or if they had fewer than 50
study participants receiving both CTA and the reference
standard. Double-checking of the eligibility of studies by
a second reviewer was not undertaken.
Part of the criteria for determining study eligibility
was that articles reported either the absolute number of
true positives, false positives, false negatives and true
negatives, or sensitivity and specificity. Due to the nat-
ure of CTA, this could have been presented at the
patient, vessel or segment level. Some papers reported
diagnostic performance results for individual coronary
arteries including the right coronary artery, left coronary
artery, left anterior descending and circumflex artery.
Most reported the results for all segments with some
papers breaking this down further to proximal and distal
segments, or side branches.
The level of analysis has implications for clinical prac-
tice. Patient-level results are the most important from a
patient management perspective because if a significant
stenosis is successfully detected then that patient will be
referred for an ICA. If results suggest no significant
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an ICA and would continue with conservative manage-
ment. At the vessel-level, if a significant stenosis is
detected in a certain artery (i.e. left anterior descending
artery), this will better inform the clinician who is to
perform the forthcoming intervention. The segment-
level analysis is valuable to gauge the diagnostic preci-
sion of the technology and can also provide useful infor-
mation for a re-vascularisation procedure, if it is
required.
Appraisal of included studies
Each of the included studies was reviewed and assigned
a level of evidence in accordance with the National
Health and Medical Research Council (NHMRC) of
Australia diagnostic levels of evidence [11]. In addition,
in accordance with the review by Mowatt and colleagues
[10], individual study quality for this update was
assessed using a modified version of the Quality Assess-
ment of Diagnostic Studies (QUADAS) tool. Quality cri-
teria were tabulated in the data extraction form, rather
than used to formulate a numeric score.
Equivocal test results
The classification of equivocal test results is important
in diagnostic intervention studies as it influences the
sensitivity, specificity, PPV, NPV and overall diagnostic
accuracy of the test. By definition it is the equivocal
tests that are most likely to be misclassified. There was
considerable variation in how equivocal results were
handled in the included studies. Some studies in the
current review treated equivocal results as test positive
(where the true disease status was known), some as false
positive, and some excluded equivocal tests from the
analysis completely. Where t h et r u ed i s e a s es t a t u si s
presented for equivocal test results but not included in
the diagnostic performance measures, the reviewer has
re-calculated these measures. Excluding equivocal results
is the least preferred methodology as it can bias results
in favour of the test. In addition, in clinical practice,
patients with either positive CTA results or non-evalu-
able test results will most probably undergo ICA [12].
Data extraction and data synthesis
In the included studies, a positive CTA or ICA test was
defined as ≥50% stenosis. Data were extracted by one
reviewer onto specifically designed data extraction
forms. The sensitivity and specificity of CTA at the
patient-level were meta-analysed using Review Manager
Version 5.0 and Metadisc Version 1.4. Pooled estimates
were provided together with 95% confidence intervals of
the estimate. The pooled estimates correspond to
weighted averages in which the weight of each study is
its sample size. Pooled confidence intervals are
calculated using an F-distribution. In addition, an assess-
ment of diagnostic threshold variation among studies
was undertaken using a summary receiver operating
characteristic (SROC) curve.
Pooled sensitivity and specificity and median (range)
PPV, NPV and overall diagnostic accuracy results were
calculated for: all vessels, individual coronary arteries
(right coronary; left coronary; left anterior descending;
and circumflex arteries) as well as all segments, using
the equivocal test result selection methodology outlined
above. The analysis of vessels did not include any sub-
group analyses that limited results by vessel size. For
patient-level analysis, forest plots were also included.
The base-case meta-analysis presented the diagnostic
performance results of CTA at the patient-level but
omitted studies that excluded equivocal test results. A
second (alternative) meta-analysis included all studies
that presented patient-level results with treatment of
equivocal test results preferentially included as follows.
The first preference was results (either as reported by
authors or re-calculated by the reviewer) with equivocal
CTA test results included and treated as test positive,
with disease status as determined by ICA correctly
assigned. The second preference was for results pre-
sented with equivocal test results treated as false posi-
tives (i.e. intent-to-diagnose principal). In this case the
ICA result for equivocal segments was unknown and
therefore could not be re-calculated. This convention
assumes that the test was classified positive and the dis-
ease state negative. The third preference was for results
presented with equivocal tests excluded.
Results
Literature search
There were 1,438 non-duplicate studies identified by the
search strategy. Ninety nine full text articles were eligi-
ble for retrieval after excluding studies based on their
title or abstract. Of the full papers retrieved, 71 did not
fulfil the eligibility criteria and were excluded. Therefore,
28 articles examining 3,674 patients were included and
fully appraised in this systematic review.
Characteristics of the included studies
The characteristics of the included studies are sum-
marised in Table 1. Of the 28 included studies, nine
were assessed as Level II diagnostic evidence, 15 were
categorised as Level III-1 evidence, and four as Level
III-2 evidence [8,12-38]. The majority were diagnostic
intervention studies in which patients presenting with
suspected CAD were prospectively analysed with 64-
slice CTA to determine whether or not they had signifi-
cant stenosis of coronary arteries. In order to validate
the CTA results, all the included studies required
patients to undergo a conventional ICA, which in some
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Author
(Year)
Type of scanner Participants
analysed (n)
Mean
age
(years)
Gender
(M/F)
Prevalence
of CAD (%)
Mean
heart rate
(± SD)
(bpm)
Level of analysis
presented in publication
Patient Vessel Segment
Level II diagnostic studies
Brodoefel et
al (2008) [8]
Somatom Sensation 64, Siemens, Germany 102 62.0 82/20 62.7 68.2 ± 13.3 No No Yes
Cademartiri
et al
(2008a) [13]
Somatom Sensation 64, Siemens, Germany 170 57.5
a 124/46 NR 62.7 ± 10.5 No No Yes
Ghostine et
al (2008)
[14]
Somatom Sensation 64, Siemens, Germany 93 65.0 61/32 46.0 73.0 ± 14.0 Yes No Yes
Husmann et
al (2008)
[15]
Somatom Sensation 64, Siemens, Germany 88 64.3 48/40 48.9 63.0 ± 9.2 Yes Yes Yes
Leber et al
(2007) [16]
Somatom Sensation 64, Siemens, Germany 90 58.0 57/33 47.7 73.0 ± NR Yes No Yes
Leschka et
al (2008a)
[17]
Somatom Sensation 64, Siemens, Germany 74 61.7 50/24 47.3 67.7 ± 13.3 Yes Yes Yes
Leschka et
al (2008b)
[18]
Somatom Sensation 64, Siemens, Germany 114 62.2 73/41 62.3 68.0 ± 13.0 Yes No Yes
Rixe et al
(2009) [19]
Somatom Sensation 64, Siemens, Germany 76 65.5 47/29 52.6 68.0 ± 9.0 Yes Yes Yes
Shabestari
et al (2007)
[20]
Somatom Sensation 64, Siemens, Germany 138 63.0 103/35 78.3 65.0 ± NR
b
Yes Yes Yes
Level III-1 diagnostic studies
Achenbach
et al (2008)
[21]
Somatom Sensation 64, Siemens Germany 200 63.0 114/86 44.5 76 ± 13 Yes Yes Yes
Budoff et al
(2008) [22]
Lightspeed VCT Scanner, GE Healthcare 230 57.0 136/94 24.8 60 ± 12 Yes Yes No
Cademartiri
et al (2007)
[23]
Somatom Sensation 64, Siemens, Germany 72 53.9 38/34 28.0 70.0 ± 9.9 Yes Yes Yes
Hausleiter
et al (2007)
[24]
Somatom Sensation 64 Cardiac, Siemens,
Germany
243 62.0 158
c/85 42.0 56.6 ± 6.5 Yes Yes Yes
Herzog et al
(2007) [25]
Somatom Sensation 64, Siemens, Germany 55 67.0 29/26 34.5 64.0 ± NR Yes Yes Yes
Meijboom
et al
(2007a) [26]
Somatom Sensation 64, Siemens, Germany 104 58.7
a 75/29 85.0 66.0 ± 9.0 Yes Yes Yes
Meijboom
et al
(2007b) [27]
Somatom Sensation 64; Siemens, Germany 402 59.2
a 279/123 62.9 59.5
a ±
NR
Yes Yes Yes
Meijboom
et al
(2007c) [28]
Somatom Sensation 64, Siemens, Germany 254 59.0
a 171/83 49.6 59.3
a ±
NR
Yes Yes Yes
Meijboom
et al (2008)
[12]
Somatom Sensation 64, Siemens, Germany;
Brilliance 64, Philips, The Netherlands;
Toshiba Multi-Slice Aquilion 64, Toshiba,
Japan
360 60.0 245/115 68.0 59 ± 9 Yes Yes Yes
Oncel et al
(2007) [29]
Somatom Sensation 64, Siemens, Germany 80 56.0 61/19 77.5 58.0 ± 10.0 Yes No Yes
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studies, however, the ICA was performed independently
of the CTA, and with the exception of two studies, it
was clear that the results of the index test had been
interpreted by a reviewer blinded to the results of the
reference standard.
Of the included studies, nine recruited patients conse-
cutively whereas 17 either recruited patients non-conse-
cutively or did not report the method of recruitment
and were consequently assumed to have recruited non-
consecutively. Two included studies were retrospective
analyses. In accordance with eligibility criteria deter-
mined ap r i o r i , each included study examined more
than 50 patients, with the number of participants ana-
lysed ranging from 51 to 402. Consistent with the gen-
der and demographic profile for CAD, more males than
females were examined in the included studies with
mean age ranging from 53.9 to 68.2 years.
The eligibility criteria of the included studies were
similar throughout. Although most studies did not expli-
citly report inclusion criteria, the study populations
included patients with suspected CAD because of a
range of symptoms (e.g. angina), usually scheduled for
ICA. Those who had undergone a previous PCI such as
stenting or CABG were excluded. Patients who had a
contraindication to CTA such as a known allergy to
iodinated contrast agent were also excluded. Other com-
mon exclusion criteria included atrial fibrillation,
impaired renal function and inability to follow the
breath hold command required to complete the test.
There were no exclusions of patients based on signifi-
cant calcification of the arteries. The majority of patients
were given beta-blockers prior to scanning in order to
reduce their heart rate.
The prevalence of CAD in the included study cohorts
ranged from 24.8%-85.0%. The lowest prevalence
(24.8%) came from the study by Budoff et al [22] who
examined patients presenting with typical or atypical
chest pain, who were being referred for ICA. The high-
est prevalence came from a study by Meijboom and col-
leagues [26] who investigated high and low risk non-ST
segment elevation in acute coronary syndrome patients
w i t hap o s i t i v eo ri n c o n c l u s i v ee x e r c i s eE C Gt e s to r
high suspicion for CAD. Patients presenting with ST-
segment elevation MI were excluded. Five other
i n c l u d e ds t u d i e sh a dap r e v a l e n c eo fC A Da b o v e7 0 . 0 % .
All five included patients presenting with typical or aty-
pical chest pain but two studies also included patients
Table 1 Summary of included study characteristics (Continued)
Piers et al
(2008) [30]
Somatom Sensation 64, Siemens, Germany 60 64.0 51/9 63.3 63.0 ± 12.0 Yes Yes Yes
Scheffel et
al (2008)
[31]
Somatom Sensation 64, Siemens, Germany 120 68.2 71/49 55.0 59.0 ± 6.0 Yes Yes Yes
Schlosser et
al (2007)
[32]
Somatom Sensation 64, Siemens, Germany 61 62.4 41/20 NR 57.0 ± 4.0 No Yes Yes
Sheth et al
(2008) [33]
Toshiba Aquilion 64-detector scanner,
Toshiba, Japan
80 56.0 43/37 39.5 NR Yes Yes Yes
Weustink et
al (2007)
[34]
DSCT Somatom Sensation 64, Siemens,
Germany.
100 61.0 79/21 77.0 68.0 ± 11.0 Yes Yes Yes
Level III-2 diagnostic studies
Cademartiri
et al
(2008b) [35]
Somatom Sensation 64 Cardiac; Siemens,
Germany
134 63.4 98/36 62.7 57.5
a ±
NR
Yes Yes Yes
Han et al
(2008) [36]
64-slice VCT; GE Healthcare 53 59.6 228
d/
175
81.1 NR No No Yes
Pugliese et
al (2008)
[37]
Somatom Sensation 64, Siemens, Germany 51 59.0 39/12 74.5 58.0 ± 7.0 Yes No Yes
Yoshida et
al (2009)
[38]
Somatom Sensation 64, Siemens, Germany 70 64.0 50/20 NR 65.0 ± 11.0 No No Yes
Bpm, beats-per-minute; CAD, coronary artery disease; F, female; M, male; NR, not reported.
Levels of evidence were defined according to the NHMRC diagnostic levels of evidence (11)
a Calculated post hoc using a crude weighted average of the two reported sub-groups
b Median heart rate
c There was a discrepancy between the number stated in Table 1 of the publication and the number stated in the text (228 and 226, respectively).
d For all enrolled patients in study
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examined patients suspectedo fh a v i n gC A D ,t h ev a r i a -
tion in prevalence reflects the level of suspicion of sig-
nificant stenosis.
Diagnostic accuracy of CTA
Forest plots with the associated sensitivity, specificity,
PPV and NPV of CTA for detecting significant stenosis
for the patient-level base case meta-analysis are shown
in Figure 1a n dFigure 2. The pooled value (95% CI)
for sensitivity and specificity and median (range) for
PPV, NPV and overall diagnostic accuracy for all levels
of analysis (i.e. patient, vessel and segment level) are
presented in Table 2.
At the patient-level, there were 18 studies included in
the base case meta-analysis and 22 studies included in
the alternative meta-analysis. Omitting studies that
excluded equivocal test results (i.e. the base case), sensi-
tivity in the included studies ranged from 90.9% to
100.0%, with a pooled sensitivity of 98.2% (97.4%-98.8%).
Specificity ranged from 45.5% to 100.0%, with a pooled
specificity of 81.6% (79.0%-84.0%). The median PPV for
the included studies was 90.5% (75.5%-100.0%), with the
median NPV 99.0% (83.3%-100.0%). There was little dif-
ference between the results of the base case and the
alternative analysis.
At the overall vessel-level, omitting studies that
excluded equivocal test results, sensitivity ranged from
87.3% to 100.0%, specificity 68.0% to 97.1%, PPV 53.4%
to 95.0%, NPV 92.7% to 100.0%, and overall diagnostic
accuracy from 73.8% to 98.0%. The results for overall ves-
sel-level analysis showed that the diagnostic performance
is similar to that of the patient-level analysis with a high
pooled sensitivity and median NPV (94.9% and 99.0%,
respectively). The sensitivity for the right coronary artery
(RCA) ranged from 89.5% to 100.0%, specificity 72.2% to
99.5%, PPV 72.5% to 94.4%, NPV 95.1% to 100.0% and
overall diagnostic accuracy 83.7% to 99.0%. For the left
main (LM) artery, the sensitivity ranged from 83.3% to
100.0%, specificity 91.1% to 100.0%, PPV 23.8% to
100.0%, NPV 97.6% to 100.0%, and overall diagnostic
accuracy 90.9% to 100.0%. For the left anterior descend-
ing (LAD) artery, the sensitivity ranged from 93.8% to
100.0%, specificity 55.8% to 92.7%, PPV 57.1% to 95.0%,
NPV 95.0% to 100.0% and overall diagnostic accuracy
71.9% to 99.0%. For the circumflex (CX) artery, the sensi-
tivity ranged from 86.6% to 100.0%, specificity 70.3% to
91.5%, PPV 51.5% to 89.7%, NPV 94.7% to 100.0% and
overall diagnostic accuracy 75.3% to 99.0%.
Pooled sensitivity remained high for each individual
vessel (94.1% to 97.4%). Specificity was slightly higher in
the LM artery 97.1% (95.7%-98.1%) and slightly lower in
the LAD artery 84.5% (82.1%-86.7%) compared with the
other arteries. The median PPV was similar across ves-
sels except for the LM, in which it was slightly higher
89.0% (24.0%-100.0%). The median NPV was consis-
tently high in each vessel (98.5% to 100.0%).
At the segment-level, sensitivity ranged from 80.7% to
100.0%, specificity 90.2% to 99.1%, PPV 43.6% to 86.4%,
NPV 97.9% to 100.0% and overall diagnostic accuracy
ranged from 90.0% to 99.1%. There were 17 studies
reporting overall segment level results. The pooled sen-
sitivity was 91.3% (90.2%-92.2%), specificity 94.0%
(93.7%-94.2%), PPV 69.0% (44.0%-86.0%), NPV 99.0%
(98.0-100.0%) and overall diagnostic accuracy 95.5%
(90.0%-99.0%).
Diagnostic threshold effect
To assess the impact of diagnostic threshold variation
between studies a symmetrical SROC curve was fitted
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(± 0.014), suggesting that variations in definition of a
p o s i t i v eC T Ar e s u l td i dn o th a v ea ni n f l u e n c eo nt h e
pooled sensitivity and specificity results.
Discussion
There has been considerable enhancement in temporal
and spatial resolution of CTA in recent years, and these
improvements appear to have contributed to the fact
that CTA now preserves a high rate of evaluable
patients. This systematic review summarized, through
meta-analysis, recent clinical evidence pertaining to the
use of 64-slice CTA in patients with suspected CAD.
The most important results from a patient manage-
ment perspective are the patient-level results. If this
technology is to be used successfully as a triage tool
then any patient without significant stenosis would not
be referred for an ICA. This may be of particular value
when access to ICA is limited. The pooled estimate
(95% CI) of sensitivity was high with CTA correctly
identifying the majority of patients who had a significant
stenosis (98.2%, 97.4%-98.8%). Perhaps more
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Figure 3 Summary receiver operator characteristic (SROC) curve for the base case patient level analysis.
Table 2 CTA diagnostic performance measures
Analysis level No. of included
studies
a
Sensitivity %
(95% CI)
Specificity %
(95% CI)
PPV Median
(range)
NPV Median
(range)
Diagnostic accuracy
Median (range)
Patient: base case
analysis
18 98.2 (97.4-98.8) 81.6 (79.0-84.0) 90.5 (76-100) 99.0 (83-100) 92.0 (80-100)
Patient: alternative
analysis
22 98.0 (97.2-98.6) 83.2 (81.1-85.2) 89.0 (63-100) 98.0 (83-100) 92.0 (80-100)
Vessels: all 17 94.9 (93.9-95.8) 89.5 (88.8-90.2) 75.0 (53-95) 99.0 (93-100) 91.5 (74-98)
RCA 8 94.8 (92.0-96.9) 91.0 (89.0-92.7) 84.0 (73-94) 98.5 (95-100) 94.5 (84-99)
LM 8 95.7 (85.2-99.5) 97.1 (95.7-98.1) 89.0 (24-100) 100.0 (98-100) 99.0 (91-100)
LAD 7 97.4 (95.3-98.8) 84.5 (82.1-86.7) 78.0 (57-95) 99.0 (95-100) 93.0 (72-99)
CX 8 94.1 (90.7-96.6) 89.6 (87.7-91.3) 78.5 (52-90) 99.5 (95-100) 94.0 (75-99)
Segments: all 17 91.3 (90.2-92.2) 94.0 (93.7-94.2) 69.0 (44-86) 99.0 (98-100) 95.5 (90-99)
CI, confidence interval; CX, circumflex; LAD, left anterior descending; LM, left main; NPV, negative predictive value; PPV, positive predictive value; RCA, right
coronary artery
a Maximum number of included studies from which data were drawn to calculate diagnostic performance measures
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(99.0%, 83-100%). NPV was above 95.0% in 14 of 18
included studies, and above 90.0% in 17 of 18 included
studies suggesting that it can reliably exclude patients
that test negative as not having significant stenosis. The
only exception was the NPV result reported in Shabestri
et al [20] where the NPV was 83.0%. No reasons were
offered by the authors as to why NPV was lower than in
previously reported studies. This study had a high pre-
valence of CAD and subsequently a relatively low num-
ber of patients classified as true negative, which may
have been why the false negative findings (four in total)
significantly influenced the NPV.
The results of the current review were similar to that
reported by Mowatt et al [10], the systematic review
that the current review sought to update. Those authors
found that sensitivity ranged from 94% to 100% with a
pooled sensitivity of 99% (95% credible interval (CrI)
97.0% to 99.0%). Specificity ranged from 50.0% to
100.0%, with a pooled specificity of 89.0% (95% CrI
83.0% to 94.0%). Across studies the median PPV was
93.0% (range 64.0% to 100.0%), while the median NPV
was 100.0% (range 86.0% to 100.0%). Comparisons with
this review are limited by the fact that Mowatt and col-
leagues [10] included patient populations with both sus-
pected and known CAD, rather than just suspected
CAD as was the case in the present review. A further
six systematic reviews were identified on this topic, all
of which had been published during or prior to 2008
[39-44]. Although the reviews varied slightly in terms of
their inclusion criteria and analyses, the broad conclu-
sions were consistent with the current systematic review.
T h er e v i e w ss u g g e s t e dh i g hd i a g n o s t i ca c c u r a c yo fC T A
validates this scanning technique as an alternative to
coronary angiography in populations suspected for cor-
onary stenosis.
It has been suggested that CTA may be able to replace
other non-invasive diagnostic imaging modalities such as
myocardial perfusion scintigraphy (MPS) and stress
ECG. A systematic review of single photon emission
computed tomography (SPECT) MPS and stress ECG
for the diagnosis and management of angina and MI,
found sensitivity ranged from 63.0% to 93.0% (median
81.0%) for SPECT and from 42.0% to 92.0% (median
65.0%) for stress ECG. Specificity ranged from 10.0% to
90.0% (median 65.0%) for SPECT and 41.0% to 88.0%
(median 67.0%) for stress ECG [7]. The range and
pooled estimate of sensitivity and specificity for the
base-case meta-analysis was higher in the current review
suggesting that CTA may have higher diagnostic accu-
racy than SPECT MPS and stress ECG in patients with
suspected CAD.
The lowest specificity (45.5%) and clear outlier in Fig-
ure 1 was reported by Piers et al [30]. The authors
attributed this low percentage to the tendency of CTA
to overestimate lesion severity (i.e. a large number of
false positives). A lower specificity was generally related
to difficulties in grading the severity of stenosis, particu-
larly in studies that included all available segments
regardless of image quality. The PPV was correlated
with the variation in prevalence of CAD in each study
cohort. As expected, those studies with a higher preva-
lence of CAD in the cohort tended to have higher PPVs.
The vessel level results are important because clini-
cians can identify which arteries contain significant ste-
nosis and match potential re-vascularisation procedures
accordingly. It is also important to know if CTA is par-
ticularly unreliable in a certain vessel. The pooled
results for overall vessel-lev e la n a l y s i ss h o w e dt h a tt h e
diagnostic performance is similar to that of the patient-
level analysis with a high sensitivity 94.9% (93.9-95.8%)
and median NPV 99.0% (93.0-100.0%). Sensitivity
remained high for each individual vessel. Specificity was
slightly higher in the LM artery and slightly lower in the
LAD artery, compared with the other arteries. The PPV
was similar across vessels except for the LM artery, in
which it was slightly higher. The NPV was consistently
high in each vessel, suggesting that CTA is no less reli-
able at excluding significants t e n o s i si nap a r t i c u l a r
artery.
The segment level results provide the most informa-
tion on the overall technical accuracy of CTA in detect-
ing significant stenosis in patients with suspected CAD.
The sensitivity of the segment level analysis is lower
than that of the vessel and patient-level analysis. This
may be because there is an increased number of equivo-
cal test results and therefore an increased proportion of
incorrectly classified segments (i.e. false negatives).
However, specificity is higher at the segment level, prob-
ably due to the increased number of true negatives
being proportionally higher than the increase in false
positives. PPV is significantly lower at the segment level
compared with the patient-level because of the increased
chance of poor image quality and therefore false positive
outcomes. Also, because the conservative approach for
clinicians reading CTA results is to treat equivocal tests
as false positive. Similar to the other levels of analysis,
NPV is high confirming the reliability of 64-slice CTA
at excluding those without significant stenosis.
The evidence considered in this review exhibited some
methodological limitations. A large variety of studies are
included, such as studies dedicated to unstable popula-
tions, studies exploring different acquisition modes (pro-
spective triggering) and as such caution should be
warranted in interpreting results. Furthermore, the
variability in prevalence of CAD in the included studies
was a limitation, particularly because of the effect it had
on the PPV. Although strict study eligibility and
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variations in the classification of suspected CAD by the
authors of the included studies and subsequent variabil-
i t yi np r e v a l e n c eo fd i s e a s ec o u l dn o tb ea v o i d e d .
Futhermore, the current review does not address the
willingness of clinicians to act upon negative CTA
results to avoid referral to ICA.
In addition, no studies of 256-slice CTA met the
inclusion criteria for the current review. Therefore, con-
clusions on the usefulness of 256-slice CTA in detecting
significant stenosis cannot be made. Due to the abun-
dance of studies conducted using 64-slice CTA since
December 2006 and methodological issues with the
meta-analyses of non-homogenous patient groups, the
patient population investigated was restricted in the cur-
rent review. As a consequence, the usefulness of CTA in
asymptomatic patients or patients with known CAD was
not examined.
Conclusions
Adoption of a new therapeutic strategy should be based
on both clinical and cost-effectiveness. This review
focused on the clinical effectiveness of CTA and results
support previous findings that concluded that the main
value of 64-slice CTA is to rule out significant CAD.
T h eh i g hN P Vo b s e r v e da tt h ep a t i e n t ,v e s s e la n ds e g -
ment level establishes CTA a sah i g h l ye f f e c t i v en o n -
invasive alternative to ICA for the exclusion of obstruc-
tive coronary artery stenosis. It should also be noted,
however, that overall diagnostic accuracy varied at the
individual artery level, with results being slightly worse
for the LAD and CX arteries compared with the RC and
LM arteries. It is unlikely that CTA will replace ICA in
assessment for revascularisation of patients, particularly
as angiography and angioplasty are often performed on
the same occasion. However, for those patients who are
candidates for standalone diagnosis with ICA, CTA may
be a viable alternative. Furthermore, in under serviced
and under resourced health areas, where invasive coron-
ary angiography is not always available, CTA appears a
viable alternative.
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